《新股消息》東軟熙康(09686.HK)今起招股 一手入場費2,985元
東軟熙康(09686.HK)公布招股詳情,擬全球發售1.34億股,香港發售佔約一成,國際發售佔約九成,每股招股價介乎4.76至5.91元。每手500股計,一手入場費2,984.8元。該股今日(18日)起招股,周四(21日)中午截止,預期下周四(28日)掛牌。獨家保薦人為中金。
公司上市引入3名基石投資者,包括寧波市產業基金、海曙投資及亞信科技(01675.HK)主席田溯寧旗下INFO EXPERT,合共認購3,000萬美元公司股份。
此外,公司料上市淨集資約6.29億元,當中約30%擬用於拓展以城市為入口的雲醫院平台;約25%用於豐富公司在整個行業價值鏈上的產品;約25%用於技術基礎設施及數據處理能力的研發;約10%將在未來3至5年用於潛在併購機會;約10%用於營運資金及其他一般公司用途。
根據弗若斯特沙利文的資料,東軟熙康打造中國首個以城市為入口的雲醫院平台,並建立一個雲醫院網絡,將地方政府、醫療機構、患者及保險公司聯繫起來,以實現公平地獲取醫療資源並更有效及高效地交付醫療服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.